Mechanisms Regulating Skin Pigmentation: The Rise and Fall of Complexion Coloration
Open accessThe DOI matches its Crossref record; 121 of the 127 references it cites were found in a registry or an index.
Abstract
Skin pigmentary abnormalities are seen as aesthetically unfavorable and have led to the development of cosmetic and therapeutic treatment modalities of varying efficacy. Hence, several putative depigmenting agents aimed at modulating skin pigmentation are currently being researched or sold in commercially available products. In this review we will discuss the regulation of processes that control skin complexion coloration. This includes direct inhibition of tyrosinase and related melanogenic enzymes, regulation of melanocyte homeostasis, alteration of constitutive and facultative pigmentation and down-regulation of melanosome transfer to the keratinocytes. These various processes, in the complex mechanism of skin pigmentation, can be regulated individually or concomitantly to alter complexion coloration and thus ameliorate skin complexion diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Scheme 1. Process of melanogenesis within epidermal melanosomes. Tyrosinase, the rate limiting enzyme of melanogenesis, catalyzes the hydroxylation of l-tyrosine to DOPA and the oxidation of DOPA to DOPAquinone. If cysteine or glutathione is present, it reacts with DOPAquinone to produce cysteinylDOPA and the benzothiazine derivatives of pheomelanin. As cysteine is diminished, DOPAquinone cyclizes into DOPAchrome. TYRP-2 catalyzes the tautomerization of DOPAchrome to 5,6-dihydroxyindole-2-carboxylic acid (DHICA), which is later oxidized to DHICA-melanin subunits. The oxidation of DHICA to eumelanin is thought to be catalyzed by TYRP-1. In the absence of TYRP-2 the carboxylic acid moiety of DOPAchrome is spontaneously lost to form 5,6-dihydroxyindole (DHI). DHICA in conjunction with DHI comprise subunits of eumelanin [11,12].](https://figures.cochat.ai/paper-figures/004566509c8849459759144469dd6b90/mechanisms-regulating-skin-pigmentation-the-rise-and-fall-of-complexion-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663 · cited 1×
“Commonly studied hydroxystilbene products include resveratrol (3,4’,5 trihydroxystilbene), its isomer oxyresveratrol and methoxylated or glycosylated analogs piceid-glucoside, rhapontigenin and rhaponticin [20,73].”
BackgroundMITF: master regulator of melanocyte development and melanoma oncogene
Levy, C., Khaled, M., & Fisher, D. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.008 · Cited by 1,169
Kim, Y.-J., & Uyama, H. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5054-y · Cited by 1,062 · cited 4×
“α-keto group show potent tyrosinase inhibition due to the similarity between the dihydroxyphenyl group of DOPA and the α-keto containing flavonoids [63].”
BackgroundInfluentialChemical and Instrumental Approaches to Treat Hyperpigmentation
Briganti, S., Camera, E., & Picardo, M. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00029.x · Cited by 837 · cited 10×
“skin pigmentation, freckles, nevi and senile lentigenes [6,10,65].”
BackgroundInfluentialMelanocytes and the Microphthalmia Transcription Factor Network
Steingrímsson, E., Copeland, N. G., & Jenkins, N. A. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.38.072902.092717 · Cited by 771 · cited 1×
“syndrome type IIA [16,17].”
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760 · cited 1×
“Pertaining to survival, MITF regulates the anti-apoptotic molecule Bcl-2 as well as additional survival genes [33,34].”
BackgroundHypopigmenting agents: an updated review on biological, chemical and clinical aspects
Solano, F., Briganti, S., Picardo, M., & Ghanem, G. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00334.x · Cited by 696 · cited 10×
“2000/6/EC) and formulations have been withdrawn from cosmetics and are available only through prescription [10,20,50].”
BackgroundInfluentialMAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes
Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T., & Fisher, D. E. (1998) · Nature · doi:10.1038/34681 · Cited by 630 · cited 1×
“ERK activation, in those cases, is thought to result in phosphorylation of MITF and its subsequent ubiquitination and degradation [25,28-30].”
BackgroundWu, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M. A., Wells, A. G., Price, E. R., Fisher, D. Z., & Fisher, D. E. (2000) · Genes & Development · doi:10.1101/gad.14.3.301 · Cited by 527 · cited 1×
“ERK activation, in those cases, is thought to result in phosphorylation of MITF and its subsequent ubiquitination and degradation [25,28-30].”
BackgroundA Chemist's View of Melanogenesis
Ito, S. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00037.x · Cited by 508 · cited 1×
“DHICA in conjunction with DHI comprise subunits of eumelanin [11,12].”
Background
Research works printed but not linked: 1
- Urabe K Nakayama J Hori Y Mixed epidermal and dermal hypermelanoses The Pigmentary System: Physiology and Pathophysiology Nordlund JJ Boissy RE Hearing VJ King RA Oetting WS Ortonne JP Oxford University Press New York, NY, USA 1998 909 913
Cited by
Items 301–325 of 325
In silico analysis of trisindoline 1 as tyrosinase inhibitors
Sukma, C. M., Nurhayati, A. P. D., & Santoso, M. (2023) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/1271/1/012084
(2024) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets48462
Verma, P. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/mr24401114122
The Remarkable Role of Nano-phytocosmeceuticals for Elevating Skincare in Facial Hyperpigmentation
Mathur, T., Jain, N., Garg, U., & Pandey, M. (2024) · Nanoscience & Nanotechnology-Asia · doi:10.2174/0122106812299476240604104440
Woodyard, J. L., & Bake, C. M. (2024) · The American Pharmacists Association eBooks · doi:10.21019/aphaotc-derm.acne
Gigantolevisins A–C, tyrosinase inhibitory benzylidenes from the shoots of Gigantochloa levis
Sagaral-Lacandalo, L., Gelani, C. D., Ohta, E., & Ohta, S. (2024) · Phytochemistry Letters · doi:10.1016/j.phytol.2024.10.003
Clinical and experimental aspects of tirbanibulin treatments
Shen, A., Simonette, R. A., Rady, P. L., & Tyring, S. K. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04119-9
“Common skin-lightening treatments in the market currently include retinoids that help fade pigmentation by accelerating skin turnover, but they show only moderate success (21% complete response, 45% partial response) and frequently cause irritation (82% of patients) [22, 23].”
Development of Poly-Herbal Formulation for Treatment of Melasma
Devarajan, A., Karim, Z., Sindhu, N., Kumar, H., Onyinechi, O. E., & George, A. M. (2025) · Journal of Ecophysiology and Occupational Health · doi:10.18311/jeoh/2025/45571
Liang, X., Xu, Y., & Hyun, C. (2025) · Oriental Journal Of Chemistry · doi:10.13005/ojc/410501
Kim, M., Lee, E., Shin, G.-E., Chin, J., An, H., Nam, S., & Lim, K. (2025) · Marine Drugs · doi:10.3390/md23120448
“Skin pigmentation is regulated by the balance between melanin synthesis and its distribution, and disruption of this equilibrium can lead to hyperpigmentation disorders, resulting in both cosmetic and psychological burdens [10].”
From Ocean to Skincare: Emerging Technologies Driving Marine-Derived Cosmetic Innovations
Said, M. S., Khalaf, M., Hamdy, M., Shehab, M., Elsebai, M., Ghoneim, M., Badr, N. H., Shoeib, N. A., & Zayed, A. (2026) · Science and Technology Nexus · doi:10.25259/stn_33_2025
Olal, C., Burch, M., & Bente, D. A. (2026) · Viruses · doi:10.3390/v18040429 · Cited by 1
Kasraian, Z. (2018) · theses.fr (ABES) · doi:10.70675/a1868dd1z7486z4a30z9abbz9078cd2b51e3
Bakuchiol: From structural mimicry to systems‐level skin biology
Chaudhuri, R. K. (2026) · International Journal of Cosmetic Science · doi:10.1111/ics.70116 · Cited by 1
Intravenous Glutathione for Skin Whitening: Safety Analysis in Healthy Individuals
Alsuwaidan, S. (2026) · Journal of Dermatology & Dermatologic Surgery · doi:10.4103/jdds.jdds_16_26
Multimechanistic Approaches for Managing Moderate Hyperpigmentation and Facial Aging
Patel, S., Kansara, V., & Shukla, H. (2026) · Journal of Dermatology & Dermatologic Surgery · doi:10.4103/jdds.jdds_13_26
Pandey, V., Shivaprasad, S., & Levingston, S. (2026) · Acta stomatologica Naissi · doi:10.5937/asn42-65147
Lu, J., Chen, M., Cai, C., He, P., Shu, D., Zhao, Y., & Jia, R. (2026) · Biology · doi:10.3390/biology15161388
“There are several ways to accomplish skin whitening, such as suppressing melanocortin 1 receptor (MC1R) or TYR activity, interfering with melanosome maturation and transfer, and inhibiting microphthalmia-associated transcription factor (MITF) [40].”
Tangonan, A. C., Kim, S. Y., & Baek, S.-H. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48101004
“These phytochemicals may suppress melanogenesis through direct inhibition of tyrosinase activity, attenuation of oxidative stress, and/or regulation of MITF and its downstream targets, including tyrosinase, TRP-1, and TRP-2 [18,19,23].”
Wang, J., Al‐gafari, M., Khosravifar, P., Kazmirchuk, T. D. D., & Ashkan, G. (2026) · Pharmaceuticals · doi:10.3390/ph19101547 · Cited by 1
“Skin tone is shaped by coordinated interactions between melanocytes and keratinocytes, enzymatic pathways involved in melanogenesis, and extracellular signals that regulate melanin production and distribution [110,111].”
BindingDB (2026) · UC San Diego · doi:10.7270/q2wh2vtq
Lee, I. J., Tam, I. N., Mooney, R. F., Overdeck, T., Kwak, L., Garza‐López, R. A., & Johal, M. S. (2026) · Langmuir · doi:10.1021/acs.langmuir.6c04466
Metadata
- Authors
- Ebanks, J. P., Wickett, R. R., & Boissy, R. E.
- Affiliations
- University of Cincinnati (US)
- Corresponding author
- Boissy, Raymond E.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2009-09-15
- Volume
- 10
- Issue
- 9
- Pages
- 4066-4087
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC2769151
- OpenAlex
- W2111479139
- Cited by
- 323
- References
- 127
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 32 · 2023: 23 · 2022: 22 · 2021: 28 · 2020: 18 · 2019: 28 · 2018: 36 · 2017: 30 · 2016: 9 · 2015: 14 · 2014: 10 · 2013: 7 · 2012: 11
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Keywords
- skin pigmentation, melanogenesis, tyrosinase inhibition, melanocyte homeostasis, melanosome transfer, keratinocytes, depigmenting agents
- MeSH terms
- Animals, Enzyme Inhibitors, Humans, Melanocytes, Protein Processing, Post-Translational, Skin Pigmentation, Monophenol Monooxygenase, Signal Transduction, Gene Expression Regulation, Enzymologic, Melanosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.